Thanks @bavarian1975
I am aware of that slide and the 2025 date mentioned on it but I am looking for a more definitive date. Dates keep slipping.
Based on the rate of progress since their Nov 2024 announcement, I am starting to think the AZER-CEL Phase 2/3 Registrational meeting and approval from the FDA is more likely to be in 2026 than 2025 - still a long way to go in the Phase1b trial and then IMU will need to prepare their pack for the FDA and get in line for a meeting.
So I am wondering whether anyone has heard IMU speak about a more realistic date and timeline for AZER-CEL's next steps.
GLTAHs
Media Thread, page-15313
-
- There are more pages in this discussion • 423 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $368.1M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 5.0¢ | 4.8¢ | $458.6K | 9.378M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1039220 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 5436876 | 20 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |